Logo image of INL.DE

INTEL CORP (INL.DE) Stock Fundamental Analysis

FRA:INL - Deutsche Boerse Ag - US4581401001 - Common Stock - Currency: EUR

18.76  +0.08 (+0.41%)

Fundamental Rating

2

Overall INL gets a fundamental rating of 2 out of 10. We evaluated INL against 58 industry peers in the Semiconductors & Semiconductor Equipment industry. INL may be in some trouble as it scores bad on both profitability and health. INL is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year INL was profitable.
INL had a positive operating cash flow in the past year.
Of the past 5 years INL 4 years were profitable.
Each year in the past 5 years INL had a positive operating cash flow.
INL.DE Yearly Net Income VS EBIT VS OCF VS FCFINL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B

1.2 Ratios

Looking at the Return On Assets, with a value of -9.55%, INL is doing worse than 87.93% of the companies in the same industry.
The Return On Equity of INL (-18.89%) is worse than 87.93% of its industry peers.
Industry RankSector Rank
ROA -9.55%
ROE -18.89%
ROIC N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
INL.DE Yearly ROA, ROE, ROICINL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

INL has a Gross Margin of 32.66%. This is amonst the worse of the industry: INL underperforms 81.03% of its industry peers.
In the last couple of years the Gross Margin of INL has declined.
The Profit Margin and Operating Margin are not available for INL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
INL.DE Yearly Profit, Operating, Gross MarginsINL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

INL does not have a ROIC to compare to the WACC, probably because it is not profitable.
INL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, INL has more shares outstanding
Compared to 1 year ago, INL has an improved debt to assets ratio.
INL.DE Yearly Shares OutstandingINL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
INL.DE Yearly Total Debt VS Total AssetsINL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

INL has an Altman-Z score of 1.15. This is a bad value and indicates that INL is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.15, INL is doing worse than 82.76% of the companies in the same industry.
INL has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
INL has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: INL underperforms 72.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 1.15
ROIC/WACCN/A
WACC9.38%
INL.DE Yearly LT Debt VS Equity VS FCFINL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 1.33 indicates that INL should not have too much problems paying its short term obligations.
INL's Current ratio of 1.33 is on the low side compared to the rest of the industry. INL is outperformed by 84.48% of its industry peers.
INL has a Quick Ratio of 1.33. This is a bad value and indicates that INL is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of INL (0.98) is worse than 77.59% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.98
INL.DE Yearly Current Assets VS Current LiabilitesINL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

The earnings per share for INL have decreased strongly by -51.92% in the last year.
The earnings per share for INL have been decreasing by -36.62% on average. This is quite bad
INL shows a decrease in Revenue. In the last year, the revenue decreased by -2.08%.
INL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.90% yearly.
EPS 1Y (TTM)-51.92%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%-75.93%
Revenue 1Y (TTM)-2.08%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%-7.44%

3.2 Future

Based on estimates for the next years, INL will show a very strong growth in Earnings Per Share. The EPS will grow by 57.55% on average per year.
Based on estimates for the next years, INL will show a small growth in Revenue. The Revenue will grow by 7.94% on average per year.
EPS Next Y1.2%
EPS Next 2Y52.61%
EPS Next 3Y50.26%
EPS Next 5Y57.55%
Revenue Next Year1.66%
Revenue Next 2Y4.32%
Revenue Next 3Y4.65%
Revenue Next 5Y7.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INL.DE Yearly Revenue VS EstimatesINL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B
INL.DE Yearly EPS VS EstimatesINL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4 5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 40.78, which means the current valuation is very expensive for INL.
INL's Price/Earnings ratio is rather expensive when compared to the industry. INL is more expensive than 81.03% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, INL is valued a bit more expensive.
With a Price/Forward Earnings ratio of 40.25, INL can be considered very expensive at the moment.
81.03% of the companies in the same industry are cheaper than INL, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, INL is valued quite expensively.
Industry RankSector Rank
PE 40.78
Fwd PE 40.25
INL.DE Price Earnings VS Forward Price EarningsINL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

INL's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.29
INL.DE Per share dataINL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
INL's earnings are expected to grow with 50.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)33.98
PEG (5Y)N/A
EPS Next 2Y52.61%
EPS Next 3Y50.26%

0

5. Dividend

5.1 Amount

No dividends for INL!.
Industry RankSector Rank
Dividend Yield N/A

INTEL CORP

FRA:INL (3/10/2025, 10:15:24 AM)

18.76

+0.08 (+0.41%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)01-30 2025-01-30/amc
Earnings (Next)04-23 2025-04-23/amc
Inst Owners66.64%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap81.23B
Analysts56.4
Price Target23.38 (24.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.34
Dividend Growth(5Y)-21.66%
DP-8.53%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)456.33%
Min EPS beat(2)2.81%
Max EPS beat(2)909.85%
EPS beat(4)3
Avg EPS beat(4)215.45%
Min EPS beat(4)-80.55%
Max EPS beat(4)909.85%
EPS beat(8)7
Avg EPS beat(8)189.09%
EPS beat(12)9
Avg EPS beat(12)123.83%
EPS beat(16)13
Avg EPS beat(16)99.49%
Revenue beat(2)2
Avg Revenue beat(2)0.63%
Min Revenue beat(2)0.02%
Max Revenue beat(2)1.23%
Revenue beat(4)2
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-2.8%
Max Revenue beat(4)1.23%
Revenue beat(8)5
Avg Revenue beat(8)0.86%
Revenue beat(12)5
Avg Revenue beat(12)-1.44%
Revenue beat(16)9
Avg Revenue beat(16)0.73%
PT rev (1m)-3.03%
PT rev (3m)-4.81%
EPS NQ rev (1m)-53.67%
EPS NQ rev (3m)-96.94%
EPS NY rev (1m)-47.45%
EPS NY rev (3m)-49.5%
Revenue NQ rev (1m)-0.23%
Revenue NQ rev (3m)-5.08%
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)-3.99%
Valuation
Industry RankSector Rank
PE 40.78
Fwd PE 40.25
P/S 1.66
P/FCF N/A
P/OCF 10.64
P/B 0.89
P/tB 1.24
EV/EBITDA 15.29
EPS(TTM)0.46
EY2.45%
EPS(NY)0.47
Fwd EY2.48%
FCF(TTM)-3.33
FCFYN/A
OCF(TTM)1.76
OCFY9.4%
SpS11.3
BVpS21.12
TBVpS15.08
PEG (NY)33.98
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.55%
ROE -18.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.66%
FCFM N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA 6.94
Cap/Depr 210.42%
Cap/Sales 45.09%
Interest Coverage N/A
Cash Conversion 124.24%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.98
Altman-Z 1.15
F-Score3
WACC9.38%
ROIC/WACCN/A
Cap/Depr(3y)223.59%
Cap/Depr(5y)192.25%
Cap/Sales(3y)44.1%
Cap/Sales(5y)35.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.92%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%-75.93%
EPS Next Y1.2%
EPS Next 2Y52.61%
EPS Next 3Y50.26%
EPS Next 5Y57.55%
Revenue 1Y (TTM)-2.08%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%-7.44%
Revenue Next Year1.66%
Revenue Next 2Y4.32%
Revenue Next 3Y4.65%
Revenue Next 5Y7.94%
EBIT growth 1Y-15287.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1367.06%
EBIT Next 3Y187.51%
EBIT Next 5Y142.17%
FCF growth 1Y-9.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.75%
OCF growth 3Y-34.47%
OCF growth 5Y-24.21%